Legal & General Group
DXCM icon

Legal & General Group’s DexCom DXCM Stock Holding History

Legal & General Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173M Sell
2,572,193
-37,161
-1% -$2.48M 0.04% 401
2026
Q1 		$164M Buy
2,609,354
+4,072
+0.2% +$284K 0.04% 399
2025
Q4 		$173M Sell
2,605,282
-30,418
-1% -$1.97M 0.04% 389
2025
Q3 		$177M Buy
2,635,700
+117,493
+5% +$9.3M 0.04% 383
2025
Q2 		$220M Sell
2,518,207
-23,015
-0.9% -$1.8M 0.05% 327
2025
Q1 		$174M Sell
2,541,222
-23,929
-0.9% -$1.95M 0.05% 371
2024
Q4 		$199M Buy
2,565,151
+129,944
+5% +$9.62M 0.05% 342
2024
Q3 		$163M Buy
2,435,207
+67,515
+3% +$5.54M 0.04% 400
2024
Q2 		$268M Sell
2,367,692
-49,501
-2% -$6.26M 0.08% 265
2024
Q1 		$335M Sell
2,417,193
-32,231
-1% -$4.05M 0.1% 223
2023
Q4 		$304M Sell
2,449,424
-48,666
-2% -$4.97M 0.09% 233
2023
Q3 		$233M Sell
2,498,090
-105,186
-4% -$11.9M 0.08% 272
2023
Q2 		$335M Buy
2,603,276
+89,358
+4% +$10.8M 0.11% 191
2023
Q1 		$292M Buy
2,513,918
+58,752
+2% +$6.58M 0.1% 217
2022
Q4 		$278M Sell
2,455,166
-128,671
-5% -$14.1M 0.11% 221
2022
Q3 		$208M Sell
2,583,837
-81,043
-3% -$6.86M 0.08% 279
2022
Q2 		$199M Buy
2,664,880
+113,876
+4% +$10.4M 0.07% 318
2022
Q1 		$326M Buy
2,551,004
+200,604
+9% +$21.9M 0.1% 227
2021
Q4 		$316M Sell
2,350,400
-158,844
-6% -$22.8M 0.1% 235
2021
Q3 		$343M Buy
2,509,244
+74,164
+3% +$9.35M 0.11% 200
2021
Q2 		$260M Buy
2,435,080
+201,324
+9% +$19.3M 0.09% 269
2021
Q1 		$201M Buy
2,233,756
+5,484
+0.2% +$515K 0.07% 308
2020
Q4 		$206M Sell
2,228,272
-47,012
-2% -$4.2M 0.08% 283
2020
Q3 		$234M Buy
2,275,284
+84,536
+4% +$8.83M 0.1% 204
2020
Q2 		$222M Buy
2,190,748
+141,180
+7% +$12.6M 0.11% 205
2020
Q1 		$138M Buy
2,049,568
+60,504
+3% +$3.76M 0.08% 271
2019
Q4 		$109M Buy
1,989,064
+67,128
+3% +$3.18M 0.05% 398
2019
Q3 		$71.7M Buy
1,921,936
+5,752
+0.3% +$223K 0.04% 489
2019
Q2 		$71.8M Sell
1,916,184
-25,004
-1% -$786K 0.04% 489
2019
Q1 		$57.8M Buy
1,941,188
+1,316,672
+211% +$46.3M 0.03% 527
2018
Q4 		$18.7M Buy
624,516
+382,548
+158% +$12.1M 0.01% 707
2018
Q3 		$8.65M Buy
241,968
+72,300
+43% +$2.24M 0.01% 914
2018
Q2 		$4.03M Sell
169,668
-10,260
-6% -$218K ﹤0.01% 1262
2018
Q1 		$3.34M Sell
179,928
-2,628
-1% -$38.9K ﹤0.01% 1329
2017
Q4 		$2.62M Sell
182,556
-200,472
-52% -$2.61M ﹤0.01% 1481
2017
Q3 		$4.68M Buy
383,028
+52,664
+16% +$931K ﹤0.01% 1075
2017
Q2 		$6.04M Buy
330,364
+26,148
+9% +$483K ﹤0.01% 887
2017
Q1 		$6.44M Buy
304,216
+106,316
+54% +$2.08M 0.01% 842
2016
Q4 		$2.95M Buy
197,900
+171,936
+662% +$3.05M ﹤0.01% 1157
2016
Q3 		$569K Buy
25,964
+4,316
+20% +$96.1K ﹤0.01% 1633
2016
Q2 		$430K Buy
21,648
+964
+5% +$16.4K ﹤0.01% 1400
2016
Q1 		$351K Buy
20,684
+4,032
+24% +$67.4K ﹤0.01% 1489
2015
Q4 		$341K Buy
16,652
+4,032
+32% +$83.9K ﹤0.01% 1490
2015
Q3 		$271K Buy
12,620
+1,536
+14% +$34.3K ﹤0.01% 1552
2015
Q2 		$222K Sell
11,084
-39,852
-78% -$700K ﹤0.01% 1701
2015
Q1 		$788K Buy
50,936
+8,232
+19% +$124K ﹤0.01% 1174
2014
Q4 		$593K Sell
42,704
-856
-2% -$10.5K ﹤0.01% 1211
2014
Q3 		$439K Buy
+43,560
New +$445K ﹤0.01% 1223

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group's DXCM Position: Q2 2026 in Review

Legal & General Group reduced its DexCom (DXCM) stake by 1.4% in Q2 2026, selling an estimated $2.48M and leaving 2,572,193 shares worth $173M. The position accounts for 0.04% of the portfolio, ranked #401.

Legal & General Group first reported a position in DXCM in Q3 2014 and has held it in 48 quarters since. The position peaked at $343M in Q3 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Legal & General Group held 2,572,193 shares of DexCom worth $173M as of Q2 2026.
  • Legal & General Group sold 37,161 DexCom shares in Q2 2026, an estimated $2.48M.
  • DexCom made up 0.04% of Legal & General Group's portfolio in Q2 2026, its #401 holding.
  • Legal & General Group first reported a position in DexCom in Q3 2014 and has held it in 48 quarters since.
  • Legal & General Group's DexCom position peaked at $343M in Q3 2021.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.